778
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting Proceedings

ORCID Icon, , , , ORCID Icon, , , , , , , , , ORCID Icon, , , , , , , , , , , , , , , , , , , , , , ORCID Icon, , ORCID Icon, , , , , , ORCID Icon, , , , , , , ORCID Icon, , , , , , , , , , , , , , , , , ORCID Icon, , , , ORCID Icon, , , , ORCID Icon, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 85-95 | Received 31 Jul 2019, Accepted 10 Jan 2020, Published online: 06 Apr 2020
 
1

ABSTRACT

An international, expert led consensus initiative was set up by the Collaborative Ocular Tuberculosis Study (COTS) group to develop systematic, evidence, and experience-based recommendations for the treatment of ocular TB using a modified Delphi technique process. In the first round of Delphi, the group identified clinical scenarios pertinent to ocular TB based on five clinical phenotypes (anterior uveitis, intermediate uveitis, choroiditis, retinal vasculitis, and panuveitis). Using an interactive online questionnaires, guided by background knowledge from published literature, 486 consensus statements for initiating ATT were generated and deliberated amongst 81 global uveitis experts. The median score of five was considered reaching consensus for initiating ATT. The median score of four was tabled for deliberation through Delphi round 2 in a face-to-face meeting. This report describes the methodology adopted and followed through the consensus process, which help elucidate the guidelines for initiating ATT in patients with choroidal TB.

Acknowledgments

There are no disclosures related to this manuscript or research work for any of the co-authors.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Supplementary Material

Supplemental data for this paper can be accessed on the here.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.